BERG, Health Biologics, Genetics & Artificial Intelligence CEO Niven Narain on the Future of Precision Medicine in Cancer Treatment. Berg is a Boston-based company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology platform. This Platform combines patient biology and artificial-intelligence-based analytics to engage the differences between healthy and disease environments. The patients own biology drives the platforms results and guides Berg in the discovery and development of precision drugs.
Podcast: Play in new window | Download